870090-58-7

Basic information

• Product Name: 1,3-Benzodioxole-5-carboxamide, N-[3-methoxy-4-[(methylsulfonyl)amino]phenyl]-
• CAS NO: 870090-58-7
• Molecular Formula: C16H16N2O6S
• Molecular Weight: 364.379
• Mol File: 870090-58-7.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 1,3-Benzodioxole-5-carboxamide, N-[3-methoxy-4-[(methylsulfonyl)amino]phenyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: 1,3-Benzodioxole-5-carboxamide, N-[3-methoxy-4-[(methylsulfonyl)amino]phenyl]-(870090-58-7)
• EPA Substance Registry System: 1,3-Benzodioxole-5-carboxamide, N-[3-methoxy-4-[(methylsulfonyl)amino]phenyl]-(870090-58-7)

Safety Data

• Hazardous Substances Data: 870090-58-7(Hazardous Substances Data)

Upstream product

• 25054-53-9 3,4-(methylenedioxy)benzoyl chloride 
• 57164-99-5 4-amino-2-methoxy-N-methanesulphonyl aniline 

Downstream Products

• 870090-57-6 N-(3-hydroxy-4-methanesulfonylaminophenyl)-3,4-dihydroxybenzamide 

Relevant articles and documents

SUBSTITUTED N-ARYL BENZAMIDES AND RELATED COMPOUNDS FOR TREATMENT OF AMYLOID DISEASES AND SYNUCLEINOPATHIES

Substituted diaryl compounds of the Formulae (I, II, III), where the variables are as defined in the claims, and their pharmaceutically acceptable derivatives, their synthesis, pharmaceutical compositions containing them, and their use in the treatment of amyloid diseases, including A? amyloidosis, such as observed in Alzheimer's disease, IAPP amyloidosis, such as observed in type 2 diabetes, and synucleinopathies, such as observed in Parkinson's disease, and the manufacture of medicaments for such treatment are provided.